zepbound

Generic: tirzepatide

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name zepbound
Generic Name tirzepatide
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

tirzepatide 2.5 mg/.5mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-2506
Product ID 0002-2506_f4a0acea-cd2f-4e90-b495-bb07116e0509
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA217806
Listing Expiration 2027-12-31
Marketing Start 2023-11-08

Pharmacologic Class

Established (EPC)
glucose-dependent insulinotropic polypeptide receptor agonist [epc] glp-1 receptor agonist [epc]
Mechanism of Action
g-protein-linked receptor interactions [moa] glucagon-like peptide-1 (glp-1) agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00022506
Hyphenated Format 0002-2506

Supplemental Identifiers

RxCUI
2601743 2601755 2601761 2601767 2601773 2601784 2644396 2644401 2644405 2644409 2644413 2644417 2669706 2669709 2669712 2669715 2669718 2669721 2679317 2679319 2679321 2679323 2679325 2679327 2732437 2732440 2732442 2732444 2732446 2732448 2732449 2732450 2732452 2732454 2732456 2732458 2734623 2734626 2734628 2734630 2734632 2734634 2734636 2734638 2734640 2734642 2734644 2734646
UPC
0300022002045 0300026210118 0300021423049 0300020152049 0300026052114 0300021214043 0300026103113 0300026612110 0300021340049 0300026304114 0300026523119 0300020243044
UNII
OYN3CCI6QE
NUI
N0000194015 N0000000152 N0000178480 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zepbound (source: ndc)
Generic Name tirzepatide (source: ndc)
Application Number NDA217806 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/.5mL
source: ndc
Packaging
  • 4 SYRINGE in 1 CARTON (0002-2506-61) / .5 mL in 1 SYRINGE
  • 4 SYRINGE in 1 CARTON (0002-2506-80) / .5 mL in 1 SYRINGE (0002-2506-01)
source: ndc

Packages (2)

0002-2506-61 4 SYRINGE in 1 CARTON (0002-2506-61) / .5 mL in 1 SYRINGE 0002-2506-80 4 SYRINGE in 1 CARTON (0002-2506-80) / .5 mL in 1 SYRINGE (0002-2506-01)

Ingredients (1)

tirzepatide (2.5 mg/.5mL)

Linked Drug Pages (1)

Zepbound, ZEPBOUND, Zepbound KwikPen ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "f4a0acea-cd2f-4e90-b495-bb07116e0509", "openfda": {"nui": ["N0000194015", "N0000000152", "N0000178480", "N0000020058"], "upc": ["0300022002045", "0300026210118", "0300021423049", "0300020152049", "0300026052114", "0300021214043", "0300026103113", "0300026612110", "0300021340049", "0300026304114", "0300026523119", "0300020243044"], "unii": ["OYN3CCI6QE"], "rxcui": ["2601743", "2601755", "2601761", "2601767", "2601773", "2601784", "2644396", "2644401", "2644405", "2644409", "2644413", "2644417", "2669706", "2669709", "2669712", "2669715", "2669718", "2669721", "2679317", "2679319", "2679321", "2679323", "2679325", "2679327", "2732437", "2732440", "2732442", "2732444", "2732446", "2732448", "2732449", "2732450", "2732452", "2732454", "2732456", "2732458", "2734623", "2734626", "2734628", "2734630", "2734632", "2734634", "2734636", "2734638", "2734640", "2734642", "2734644", "2734646"], "spl_set_id": ["487cd7e7-434c-4925-99fa-aa80b1cc776b"], "pharm_class_epc": ["Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]", "GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["G-Protein-linked Receptor Interactions [MoA]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "4 SYRINGE in 1 CARTON (0002-2506-61)  / .5 mL in 1 SYRINGE", "package_ndc": "0002-2506-61", "marketing_start_date": "20231108"}, {"sample": false, "description": "4 SYRINGE in 1 CARTON (0002-2506-80)  / .5 mL in 1 SYRINGE (0002-2506-01)", "package_ndc": "0002-2506-80", "marketing_start_date": "20231108"}], "brand_name": "ZEPBOUND", "product_id": "0002-2506_f4a0acea-cd2f-4e90-b495-bb07116e0509", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["G-Protein-linked Receptor Interactions [MoA]", "GLP-1 Receptor Agonist [EPC]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]", "Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]"], "product_ndc": "0002-2506", "generic_name": "tirzepatide", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZEPBOUND", "active_ingredients": [{"name": "TIRZEPATIDE", "strength": "2.5 mg/.5mL"}], "application_number": "NDA217806", "marketing_category": "NDA", "marketing_start_date": "20231108", "listing_expiration_date": "20271231"}